Methylene blue rescues heart defects in a drosophila model of friedreich's ataxia

Human Molecular Genetics

Volumn 23, Issue 4, 2014, Pages 968-979

  Tricoire, Hervé ^a   Palandri, Amandine ^a   Bourdais, Arthur ^b   Camadro, Jean Michel ^b   Monnier, Véronique ^a  

^a Groupe Hospitalier Pitié Salpêtrière   (France)

^b INSTITUT JACQUES MONOD   (France)

Author keywords

[No Author keywords available]

Indexed keywords

FRATAXIN; IDEBENONE; METHYLENE BLUE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARDIAC IMAGING; CARDIOVASCULAR PARAMETERS; COMPLEX I DEFICIENCY; COMPLEX III DEFICIENCY; CONTROLLED STUDY; DROSOPHILA MELANOGASTER; END DIASTOLIC DIAMETER; END SYSTOLIC DIAMETER; FRACTIONAL SHORTENING; FRIEDREICH ATAXIA; HEART DILATATION; HEART DISEASE; HEART FUNCTION; HEART PROTECTION; IN VIVO STUDY; MITOCHONDRIAL RESPIRATION; NONHUMAN; OXIDATIVE STRESS; PALLIATIVE THERAPY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEPLETION; RESPIRATORY CHAIN;

ANIMALS; CARDIOTONIC AGENTS; DISEASE MODELS, ANIMAL; DROSOPHILA MELANOGASTER; DROSOPHILA PROTEINS; DRUG EVALUATION, PRECLINICAL; FRIEDREICH ATAXIA; GENE KNOCKDOWN TECHNIQUES; HUMANS; IRON-BINDING PROTEINS; MALE; METHYLENE BLUE; RNA INTERFERENCE; UBIQUINONE;

EID: 84893053536     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddt493     Document Type: Article

References (91)

1. Durr, A., Cossee, M., Agid, Y., Campuzano, V., Mignard, C., Penet, C., Mandel, J.L., Brice, A. and Koenig, M. (1996) Clinical and genetic abnormalities in patients with Friedreich's ataxia. N. Engl. J. Med., 335, 1169-1175.
2. Harding, A.E. (1981) Friedreich's ataxia: a clinical and genetic study of 90 families with an analysis of early diagnostic criteria and intrafamilial clustering of clinical features. Brain, 104, 589-620.
3. Pandolfo, M. (2009) Friedreich ataxia: the clinical picture. J. Neurol., 256 Suppl 1, 3-8.
4. Tsou, A.Y., Paulsen, E.K., Lagedrost, S.J., Perlman, S.L., Mathews, K.D., Wilmot, G.R., Ravina, B., Koeppen, A.H. and Lynch, D.R. (2011) Mortality in Friedreich ataxia. J. Neurol. Sci., 307, 46-49.
5. Friedreich, N. (1863) Uber degenerative Atrophie der spinalen Hinterstrange. Virchows Arch. Pathol. Anat., 26, 391-419, 433-459; 327, 391-326.
6. Weidemann,F.,Rummey,C., Bijnens, B., Stork, S., Jasaityte, R., Dhooge, J., Baltabaeva, A., Sutherland, G., Schulz, J.B. and Meier, T. (2012)The heart in Friedreich ataxia: definition of cardiomyopathy, disease severity, and correlation with neurological symptoms. Circulation, 125, 1626-1634.
7. Casazza, F. and Morpurgo, M. (1996) The varying evolution of Friedreich's ataxia cardiomyopathy. Am. J. Cardiol., 77, 895-898.
8. Child, J.S., Perloff, J.K., Bach, P.M., Wolfe, A.D., Perlman, S. and Kark, R.A. (1986) Cardiac involvement in Friedreich's ataxia: a clinical study of 75 patients. J. Am. Coll. Cardiol., 7, 1370-1378.
9. Dutka, D.P., Donnelly, J.E., Palka, P., Lange, A., Nunez, D.J. and Nihoyannopoulos, P. (2000) Echocardiographic characterization of cardiomyopathy in Friedreich's ataxia with tissue Doppler echocardiographically derived myocardial velocity gradients. Circulation, 102, 1276-1282.
10. Giunta, A., Maione, S., Biagini, R., Filla, A., De Michele, G. and Campanella, G. (1988) Noninvasive assessment of systolic and diastolic function in 50 patients with Friedreich's ataxia. Cardiology, 75, 321-327.
11. Hawley, R.J. and Gottdiener, J.S. (1986) Five-year follow-up of Friedreich's ataxia cardiomyopathy. Arch. Intern. Med., 146, 483-488.
12. Kipps, A., Alexander, M., Colan, S.D., Gauvreau, K., Smoot, L., Crawford, L., Darras, B.T. and Blume, E.D. (2009) The longitudinal course of cardiomyopathy in Friedreich's ataxia during childhood. Pediatr. Cardiol., 30, 306-310.
13. Morvan, D., Komajda, M., Doan, L.D., Brice, A., Isnard, R., Seck, A., Lechat, P., Agid, Y. and Grosgogeat, Y. (1992) Cardiomyopathy in Friedreich's ataxia: a Doppler-echocardiographic study. Eur. Heart J., 13, 1393-1398.
14. Unverferth, D.V., Schmidt, W.R. 2nd, Baker, P.B. and Wooley, C.F. (1987) Morphologic and functional characteristics of the heart in Friedreich's ataxia. Am. J. Med., 82, 5-10.
15. Raman, S.V., Phatak, K., Hoyle, J.C., Pennell, M.L., McCarthy, B., Tran, T., Prior, T.W., Olesik, J.W., Lutton, A., Rankin, C. et al. (2011) Impaired myocardial perfusion reserve and fibrosis in Friedreich ataxia: a mitochondrial cardiomyopathy with metabolic syndrome. Eur. Heart J., 32, 561-567.
16. Campuzano, V., Montermini, L., Molto, M.D., Pianese, L., Cossee, M., Cavalcanti, F., Monros, E., Rodius, F., Duclos, F., Monticelli, A. et al. (1996) Friedreich's ataxia: autosomal recessive disease caused by an intronicGAA triplet repeat expansion. Science, 271, 1423-1427.
17. Pandolfo, M. and Pastore, A. (2009) The pathogenesis of Friedreich ataxia and the structure and function of frataxin. J. Neurol., 256 Suppl 1, 9-17.
18. Santos, R., Lefevre, S., Sliwa, D., Seguin, A., Camadro, J.M. and Lesuisse, E. (2010) Friedreich ataxia: molecular mechanisms, redox considerations, and therapeutic opportunities. Antioxid. Redox Signal., 13, 651-690.
19. Rotig, A., de Lonlay, P., Chretien, D., Foury, F., Koenig, M., Sidi, D., Munnich,A. and Rustin, P. (1997) Aconitase and mitochondrial iron-sulphur protein deficiency in Friedreich ataxia. Nat. Genet., 17, 215-217.
20. Wong, A., Yang, J., Cavadini, P., Gellera, C., Lonnerdal, B., Taroni, F. and Cortopassi, G. (1999) The Friedreich's ataxia mutation confers cellular sensitivity to oxidant stress which is rescued by chelators of iron and calcium and inhibitors of apoptosis. Hum. Mol. Genet., 8, 425-430.
21. Babcock, M., de Silva, D., Oaks, R., Davis-Kaplan, S., Jiralerspong, S., Montermini, L., Pandolfo, M. and Kaplan, J. (1997) Regulation of mitochondrial iron accumulation by Yfh1p, a putative homolog of frataxin. Science, 276, 1709-1712.
22. Huang, M.L., Becker, E.M., Whitnall, M., Suryo Rahmanto, Y., Ponka, P. and Richardson, D.R. (2009) Elucidation of the mechanismof mitochondrial iron loading in Friedreich's ataxia by analysis of a mouse mutant. Proc. Natl. Acad. Sci. USA, 106, 16381-16386.
23. Puccio, H., Simon, D., Cossee, M., Criqui-Filipe, P., Tiziano, F., Melki, J., Hindelang, C., Matyas, R., Rustin, P. and Koenig, M. (2001) Mouse models for Friedreich ataxia exhibit cardiomyopathy, sensory nerve defect and Fe-S enzyme deficiency followed by intramitochondrial iron deposits. Nat. Genet., 27, 181-186.
24. Al-Mahdawi, S., Pinto, R.M., Ruddle, P., Carroll, C., Webster, Z. and Pook, M.(2004)GAARepeat instability in Friedreich ataxiaYACtransgenic mice. Genomics, 84, 301-310.
25. Cossee, M., Puccio, H., Gansmuller, A., Koutnikova, H., Dierich, A., LeMeur, M., Fischbeck, K., Dolle, P. and Koenig, M. (2000) Inactivation of the Friedreich ataxia mouse gene leads to early embryonic lethality without iron accumulation. Hum. Mol. Genet., 9, 1219-1226.
26. Miranda, C.J., Santos, M.M., Ohshima, K., Smith, J., Li, L., Bunting, M., Cossee, M., Koenig, M., Sequeiros, J., Kaplan, J. et al. (2002) Frataxin knockin mouse. FEBS Lett., 512, 291-297.
27. Puccio, H. (2009) Multicellular models of Friedreich ataxia. J. Neurol., 256 Suppl 1, 18-24.
28. Ristow, M., Mulder, H., Pomplun, D., Schulz, T.J., Muller-Schmehl, K., Krause, A., Fex, M., Puccio, H., Muller, J., Isken, F. et al. (2003) Frataxin deficiency in pancreatic islets causes diabetes due to loss of beta cell mass. J. Clin. Invest., 112, 527-534.
29. Simon, D., Seznec, H., Gansmuller, A., Carelle, N., Weber, P., Metzger, D., Rustin, P., Koenig,M.and Puccio, H. (2004) Friedreich ataxia mousemodels with progressive cerebellar and sensory ataxia reveal autophagic neurodegeneration in dorsal root ganglia. J. Neurosci., 24, 1987-1995.
30. Thierbach, R., Schulz, T.J., Isken, F., Voigt, A., Mietzner, B., Drewes, G., von Kleist-Retzow, J.C., Wiesner, R.J., Magnuson, M.A., Puccio, H. et al. (2005) Targeted disruption of hepatic frataxin expression causes impaired mitochondrial function, decreased life span and tumor growth in mice. Hum. Mol. Genet., 14, 3857-3864.
31. Seznec, H., Simon, D., Bouton, C., Reutenauer, L., Hertzog, A., Golik, P., Procaccio, V., Patel, M., Drapier, J.C., Koenig, M. et al. (2005) Friedreich ataxia: the oxidative stress paradox. Hum. Mol. Genet., 14, 463-474.
32. Coppola, G., Marmolino, D., Lu, D., Wang, Q., Cnop, M., Rai, M., Acquaviva, F., Cocozza, S., Pandolfo, M. and Geschwind, D.H. (2009) Functional genomic analysis of frataxin deficiency reveals tissue-specific alterations and identifies the PPARgamma pathway as a therapeutic target in Friedreich's ataxia. Hum. Mol. Genet., 18, 2452-2461.
33. Marmolino, D., Manto, M., Acquaviva, F., Vergara, P., Ravella, A., Monticelli, A. and Pandolfo,M.(2010) PGC-1alphadown-regulation affects the antioxidant response in Friedreich's ataxia. PLoS ONE, 5, e10025.
34. Seznec, H., Simon, D., Monassier, L., Criqui-Filipe, P., Gansmuller, A., Rustin, P., Koenig, M. and Puccio, H. (2004) Idebenone delays the onset of cardiac functional alteration without correction of Fe-S enzymes deficit in a mouse model for Friedreich ataxia. Hum. Mol. Genet., 13, 1017-1024.
35. Marmolino, D., Acquaviva, F., Pinelli, M., Monticelli, A., Castaldo, I., Filla, A. and Cocozza, S. (2009) PPAR-gamma agonist Azelaoyl PAF increases frataxin protein and mRNA expression: new implications for the Friedreich's ataxia therapy. Cerebellum, 8, 98-103.
36. Navarro, J.A., Ohmann, E., Sanchez, D., Botella, J.A., Liebisch, G., Molto, M.D., Ganfornina, M.D., Schmitz, G. and Schneuwly, S. (2010) Altered lipid metabolism in a Drosophila model of Friedreich's ataxia. Hum. Mol. Genet., 19, 2828-2840.
37. Gonzalez-Cabo, P., Ros, S. and Palau, F. (2010) Flavin adenine dinucleotide rescues the phenotype of frataxin deficiency. PLoS ONE, 5, e8872.
38. Kondapalli, K.C., Kok, N.M., Dancis, A. and Stemmler, T.L. (2008) Drosophila frataxin: an iron chaperone during cellular Fe-S cluster bioassembly. Biochemistry, 47, 6917-6927.
39. Anderson, P.R., Kirby, K., Orr, W.C., Hilliker, A.J. and Phillips, J.P. (2008) Hydrogen peroxide scavenging rescues frataxin deficiency in a Drosophila model of Friedreich's ataxia. Proc. Natl. Acad. Sci. USA, 105, 611-616.
40. Llorens, J.V., Navarro, J.A., Martinez-Sebastian, M.J., Baylies, M.K., Schneuwly, S., Botella, J.A. and Molto, M.D. (2007) Causative role of oxidative stress in a Drosophila model of Friedreich ataxia. FASEB J., 21, 333-344.
41. Ventura, N., Rea, S.L., Handerson, S.T., Condo, I., Testi, R. and Johnson, T.E. (2006) C. elegans as a model for Friedreich Ataxia. FASEB J., 20, 1029-1030.
42. Anderson, P.R., Kirby, K., Hilliker, A.J. and Phillips, J.P. (2005) RNAi-mediated suppression of the mitochondrial iron chaperone, frataxin, in Drosophila. Hum. Mol. Genet., 14, 3397-3405.
43. Rojas, J.C., Simola, N., Kermath, B.A., Kane, J.R., Schallert, T. and Gonzalez-Lima, F. (2009) Striatal neuroprotection with methylene blue. Neuroscience, 163, 877-889.
44. Wen, Y., Li, W., Poteet, E.C., Xie, L., Tan, C., Yan, L.J., Ju, X., Liu, R., Qian, H., Marvin, M.A. et al. (2011) Alternative mitochondrial electron transfer as a novel strategy for neuroprotection. J. Biol. Chem., 286, 16504-16515.
45. Schirmer, R.H., Adler, H., Pickhardt, M. and Mandelkow, E. (2011) Lest we forget you-methylene blue. . . Neurobiol. Aging, 32, 2325.e7-2325.e16. .
46. Monnier, V., Iche-Torres, M., Rera, M., Contremoulins, V., Guichard, C., Lalevee, N., Tricoire, H. and Perrin, L. (2012) Djun and Vri/dNFIL3 are major regulators of cardiac aging in Drosophila. PLoS Genet., 8, e1003081.
47. Bradley, J.L., Blake, J.C., Chamberlain, S., Thomas, P.K., Cooper, J.M. and Schapira, A.H. (2000) Clinical, biochemical and molecular genetic correlations in Friedreich's ataxia. Hum. Mol. Genet., 9, 275-282.
48. Cheng, Z., Tsuda, M., Kishita, Y., Sato, Y. and Aigaki, T. (2013) Impaired energy metabolism in a Drosophila model of mitochondrial aconitase deficiency. Biochem. Biophys. Res. Commun., 433, 145-150.
49. Gillis, J.C., Benefield, P. and McTavish, D. (1994) Idebenone.Areview of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in age-related cognitive disorders. Drugs Aging, 5, 133-152.
50. Mordente, A., Martorana, G.E., Minotti, G. and Giardina, B. (1998) Antioxidant properties of 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone (idebenone). Chem. Res. Toxicol., 11, 54-63.
51. Sugiyama, Y. and Fujita, T. (1985) Stimulation of the respiratory and phosphorylating activities in rat brain mitochondria by idebenone (CV-2619), a new agent improving cerebral metabolism. FEBS Lett., 184, 48-51.
52. Suno, M. and Nagaoka, A. (1984) Inhibition of lipid peroxidation by a novel compound (CV-2619) in brain mitochondria and mode of action of the inhibition. Biochem. Biophys. Res. Commun., 125, 1046-1052.
53. Lagedrost, S.J., Sutton, M.S., Cohen, M.S., Satou, G.M., Kaufman, B.D., Perlman, S.L., Rummey, C., Meier, T. and Lynch, D.R. (2011) Idebenone in Friedreich ataxia cardiomyopathy-results from a 6-month phase III study (IONIA). Am. Heart J., 161, 639-645 e631.
54. Meier, T. and Buyse, G. (2009) Idebenone: an emerging therapy for Friedreich ataxia. J. Neurol., 256 Suppl 1, 25-30.
55. Bruchey, A.K. and Gonzalez-Lima, F. (2008) Behavioral, physiological and biochemical hormetic responses to the autoxidizable dye methylene blue. Am. J. Pharmacol. Toxicol., 3, 72-79.
56. Poteet, E., Winters, A., Yan, L.J., Shufelt, K., Green, K.N., Simpkins, J.W., Wen, Y. and Yang, S.H. (2012) Neuroprotective actions of methylene blue and its derivatives. PLoS ONE, 7, e48279.
57. Medioni, C., Senatore, S., Salmand, P.A., Lalevee, N., Perrin, L. and Semeriva, M. (2009) The fabulous destiny of the Drosophila heart. Curr. Opin. Genet. Dev., 19, 518-525.
58. Nishimura, M., Ocorr, K., Bodmer, R. and Cartry, J. (2011) Drosophila as a model to study cardiac aging. Exp. Gerontol., 46, 326-330.
59. Fink, M., Callol-Massot, C., Chu, A., Ruiz-Lozano, P., Izpisua Belmonte, J.C., Giles, W., Bodmer, R. and Ocorr, K. (2009)Anew method for detection and quantification of heartbeat parameters in Drosophila, zebrafish, and embryonic mouse hearts. Biotechniques, 46, 101-113.
60. Wessells, R.J., Fitzgerald, E., Cypser, J.R., Tatar, M. and Bodmer, R. (2004) Insulin regulation of heart function in aging fruit flies. Nat. Genet., 36, 1275-1281.
61. Wolf, M.J., Amrein, H., Izatt, J.A., Choma, M.A., Reedy, M.C. and Rockman, H.A. (2006) Drosophila as a model for the identification of genes causing adult human heart disease. Proc. Natl. Acad. Sci. USA, 103, 1394-1399.
62. Emond, M., Lepage, G., Vanasse, M. and Pandolfo, M. (2000) Increased levels of plasma malondialdehyde in Friedreich ataxia. Neurology, 55, 1752-1753.
63. Piemonte, F., Pastore, A., Tozzi, G., Tagliacozzi, D., Santorelli, F.M., Carrozzo, R., Casali, C., Damiano, M., Federici, G. and Bertini, E. (2001) Glutathione in blood of patients with Friedreich's ataxia. Eur. J. Clin. Invest., 31, 1007-1011.
64. Schulz, J.B., Dehmer, T., Schols, L., Mende, H., Hardt, C., Vorgerd, M., Burk, K., Matson, W., Dichgans, J., Beal, M.F. et al. (2000) Oxidative stress in patients with Friedreich ataxia. Neurology, 55, 1719-1721.
65. Chantrel-Groussard, K., Geromel, V., Puccio, H., Koenig, M., Munnich, A., Rotig, A. and Rustin, P. (2001) Disabled early recruitment of antioxidant defenses in Friedreich's ataxia. Hum. Mol. Genet., 10, 2061-2067.
66. Kawakami, S., Matsuda, A., Sunagawa, T., Noda, Y., Kaneko, T., Tahara, S., Hiraumi, Y., Adachi, S., Matsui, H., Ando, K. et al. (2009) Antioxidant, EUK-8, prevents murine dilated cardiomyopathy. Circ. J., 73, 2125-2134.
67. Morten, K.J., Ackrell, B.A. and Melov, S. (2006) Mitochondrial reactive oxygen species in mice lacking superoxide dismutase 2: attenuation via antioxidant treatment. J. Biol. Chem., 281, 3354-3359.
68. Fosslien, E. (2003) Review: Mitochondrial medicine-cardiomyopathy caused by defective oxidative phosphorylation. Ann. Clin. Lab. Sci., 33, 371-395.
69. Limongelli, G., Masarone, D., D'Alessandro, R. and Elliott, P.M. (2012) Mitochondrial diseases and the heart: an overview of molecular basis, diagnosis, treatment and clinical course. Future Cardiol., 8, 71-88.
70. Lebon, S., Minai, L., Chretien, D., Corcos, J., Serre, V., Kadhom, N., Steffann, J., Pauchard, J.Y., Munnich, A., Bonnefont, J.P. et al. (2007) A novel mutation of theNDUFS7 gene leads to activation of a cryptic exon and impaired assembly of mitochondrial complex I in a patient with Leigh syndrome. Mol. Genet. Metab., 92, 104-108.
71. Lebon, S., Rodriguez, D., Bridoux, D., Zerrad, A., Rotig, A., Munnich, A., Legrand, A. and Slama, A. (2007)A novel mutation in the human complex I NDUFS7 subunit associated with Leigh syndrome. Mol. Genet. Metab., 90, 379-382.
72. Triepels, R.H., van den Heuvel, L.P., Loeffen, J.L., Buskens, C.A., Smeets, R.J., Rubio Gozalbo, M.E., Budde, S.M., Mariman, E.C., Wijburg, F.A., Barth, P.G. et al. (1999) Leigh syndrome associated with a mutation in the NDUFS7 (PSST) nuclear encoded subunit of complex I. Ann. Neurol., 45, 787-790.
73. Ngu, L.H., Nijtmans, L.G., Distelmaier, F., Venselaar, H., van Emst-de Vries, S.E., van den Brand, M.A., Stoltenborg, B.J., Wintjes, L.T., Willems, P.H., van den Heuvel, L.P. et al. (2012) A catalytic defect in mitochondrial respiratory chain complex I due to a mutation in NDUFS2 in a patient with Leigh syndrome. Biochim. Biophys. Acta., 1822, 168-175.
74. Whitnall, M., Suryo Rahmanto, Y., Huang, M.L., Saletta, F., Lok, H.C., Gutierrez, L., Lazaro, F.J., Fleming, A.J., St Pierre, T.G., Mikhael, M.R. et al. (2012) Identification of nonferritin mitochondrial iron deposits in a mouse model of Friedreich ataxia. Proc. Natl. Acad. Sci. USA, 109, 20590-20595.
75. Whitnall, M., Suryo Rahmanto, Y., Sutak, R., Xu, X., Becker, E.M., Mikhael, M.R., Ponka, P. and Richardson, D.R. (2008) The MCK mouse heart model of Friedreich's ataxia: alterations in iron-regulated proteins and cardiac hypertrophy are limited by iron chelation. Proc. Natl. Acad. Sci. USA, 105, 9757-9762.
76. Atamna, H., Nguyen, A., Schultz, C., Boyle, K., Newberry, J., Kato, H. and Ames, B.N. (2008) Methylene blue delays cellular senescence and enhances key mitochondrial biochemical pathways. FASEB J., 22, 703-712.
77. Callaway, N.L., Riha, P.D., Bruchey, A.K., Munshi, Z. and Gonzalez-Lima, F. (2004) Methylene blue improves brain oxidative metabolism and memory retention in rats. Pharmacol. Biochem. Behav., 77, 175-181.
78. Richardson, T.E., Kelly, H.N., Yu, A.E. and Simpkins, J.W. (2013) Therapeutic strategies in Friedreich's ataxia. Brain Res., 1514, 91-97.
79. Betten, D.P., Vohra, R.B., Cook, M.D., Matteucci, M.J. and Clark, R.F. (2006) Antidote use in the critically ill poisoned patient. J. Intensive Care Med., 21, 255-277.
80. Cawein, M., Behlen, C.H. 2nd, Lappat, E.J. and Cohn, J.E. (1964) Hereditary diaphorase deficiency and methemoglobinemia. Arch. Intern. Med., 113, 578-585.
81. Mansouri, A. and Lurie, A.A. (1993) Concise review: methemoglobinemia. Am. J. Hematol., 42, 7-12.
82. Pelgrims, J., De Vos, F., Van den Brande, J., Schrijvers, D., Prove, A. and Vermorken, J.B. (2000) Methylene blue in the treatment and prevention of ifosfamide-induced encephalopathy: report of 12 cases and a review of the literature. Br. J. Cancer., 82, 291-294.
83. Vaccaro, A., Tauffenberger, A., Ash, P.E., Carlomagno, Y., Petrucelli, L. and Parker, J.A. (2012) TDP-1/TDP-43 regulates stress signaling and age-dependent proteotoxicity in Caenorhabditis elegans. PLoS Genet., 8, e1002806.
84. Dibaj, P., Zschuntzsch, J., Steffens, H., Scheffel, J., Goricke, B., Weishaupt, J.H., Le Meur, K., Kirchhoff, F., Hanisch, U.K., Schomburg, E.D. et al. (2012) Influence of methylene blue on microglia-induced inflammation and motor neuron degeneration in the SOD1(G93A) model for ALS. PLoSONE, 7, e43963.
85. Medina, D.X., Caccamo, A. and Oddo, S. (2011) Methylene blue reduces abeta levels and rescues early cognitive deficit by increasing proteasome activity. Brain Pathol., 21, 140-149.
86. Congdon, E.E.,Wu,J.W., Myeku, N., Figueroa, Y.H., Herman, M., Marinec, P.S., Gestwicki, J.E., Dickey, C.A., Yu, W.H. and Duff, K.E. (2012) Methylthioninium chloride (methylene blue) induces autophagy and attenuates tauopathy in vitro and in vivo. Autophagy, 8, 609-622.
87. van Bebber, F., Paquet, D., Hruscha, A., Schmid, B. and Haass, C. (2010) Methylene blue fails to inhibit Tau and polyglutamine protein dependent toxicity in zebrafish. Neurobiol. Dis., 39, 265-271.
88. Furian, A.F., Fighera, M.R., Oliveira, M.S., Ferreira, A.P., Fiorenza, N.G., de Carvalho Myskiw, J., Petry, J.C., Coelho, R.C., Mello, C.F. and Royes, L.F. (2007) Methylene blue prevents methylmalonate-induced seizures and oxidative damage in rat striatum. Neurochem. Int., 50, 164-171.
89. Zhang, X., Rojas, J.C. and Gonzalez-Lima, F. (2006) Methylene blue prevents neurodegeneration caused by rotenone in the retina. Neurotox. Res., 9, 47-57.
90. Tricoire, H., Battisti, V., Trannoy, S., Lasbleiz, C., Pret, A.M. and Monnier, V. (2009) The steroid hormone receptor EcR finely modulates Drosophila lifespan during adulthood in a sex-specific manner. Mech. Ageing Dev., 130, 547-552.
91. Rera, M., Monnier, V. and Tricoire, H. (2010) Mitochondrial electron transport chain dysfunction during development does not extend lifespan in Drosophila melanogaster. Mech. Ageing Dev., 131, 156-164.